Mitotic kinesin inhibitors

Details for Australian Patent Application No. 2005319455 (hide)

Owner Merck & Co., Inc.

Inventors Coleman, Paul J.; Roecker, Anthony J.; Mercer, Swati P.

Agent Spruson & Ferguson

Pub. Number AU-A-2005319455

PCT Pub. Number WO2006/068933

Priority 60/637,722 21.12.04 US

Filing date 15 December 2005

Wipo publication date 29 June 2006

International Classifications

C07D 231/06 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/415 (2006.01) - 1,2-Diazoles

C07D 231/10 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Event Publications

28 June 2007 PCT application entered the National Phase

  PCT publication WO2006/068933 Priority application(s): WO2006/068933

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005319456-Devices for storing and dispensing compositions

2005319454-Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders